BIOLASE Inc (NASDAQ:BIOL)
| 0.4376 Delayed Data As of Jun 02 |  +0.0276 / +6.65%Today’s Change | 0.21 Today|||52-Week Range 2.07 | -20.83% Year-to-Date |
Latest BIOL News | Press Releases
No recent news for BIOLASE Inc.
Today’s Trading
| Previous close | 0.42 |
| Today’s open | 0.43 |
| Day’s range | 0.40 - 0.45 |
| Volume | 1,739,311 |
| Average volume (3 months) | 2,084,440 |
| Market cap | $13.1M |
Data as of 5:54pm ET, 06/02/2020
Growth & Valuation
| Earnings growth (last year) | +26.36% |
| Earnings growth (this year) | +33.77% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -18.10% |
| P/E ratio | NM |
| Price/Sales | 0.34 |
| Price/Book | 34.36 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PDEXPro-Dex Inc | -0.45 | -2.26% |
| MLSSMilestone Scientific... | -0.01 | -0.50% |
| ---- | ||
| XRAYDENTSPLY SIRONA Inc | +0.27 | +0.57% |
Data as of 3:59pm ET, 06/02/2020
Financials
| Next reporting date | August 5, 2020 |
| EPS forecast (this quarter) | -$0.16 |
| Annual revenue (last year) | $37.8M |
| Annual profit (last year) | -$17.9M |
| Net profit margin | -47.24% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Irvine, California |
Forecasts
